BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 283 filers reported holding BIONTECH SE in Q1 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $564,939 | -57.7% | 5,200 | -57.9% | 0.00% | -50.0% |
| Q2 2023 | $1,334,026 | -22.2% | 12,360 | -10.2% | 0.00% | -33.3% |
| Q1 2023 | $1,714,594 | -23.6% | 13,764 | -7.9% | 0.00% | -40.0% |
| Q4 2022 | $2,244,020 | +25.3% | 14,938 | +12.5% | 0.01% | +25.0% |
| Q3 2022 | $1,791,000 | +9.4% | 13,278 | +20.9% | 0.00% | 0.0% |
| Q2 2022 | $1,637,000 | +100.1% | 10,981 | +128.9% | 0.00% | +100.0% |
| Q1 2022 | $818,000 | -45.8% | 4,798 | -18.0% | 0.00% | -33.3% |
| Q4 2021 | $1,508,000 | -39.4% | 5,848 | -35.8% | 0.00% | -40.0% |
| Q3 2021 | $2,487,000 | +87.6% | 9,109 | +53.8% | 0.01% | +66.7% |
| Q2 2021 | $1,326,000 | +30.0% | 5,921 | -36.6% | 0.00% | +50.0% |
| Q1 2021 | $1,020,000 | +29.8% | 9,342 | -3.1% | 0.00% | 0.0% |
| Q4 2020 | $786,000 | -4.1% | 9,642 | -18.6% | 0.00% | 0.0% |
| Q3 2020 | $820,000 | +27.7% | 11,843 | +23.1% | 0.00% | 0.0% |
| Q2 2020 | $642,000 | – | 9,617 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |